Table 1. Baseline Findings Between Groups^a.

	Glibenclamide Group (n = 20)	Control Group (n = 20)	P Value
Age, y (mean ± SD)	31.15 ± 10.33	30.40 ± 13.16	0.84
Gender
Male	18 (90)	20 (100)	0.48
Female	2 (10)	0
GCS			-
9 - 12	1 (5)	0
3 - 8	19 (95)	20 (100)

Abbreviations: GCS: glasgow coma scale.

^aValues are expressed as No. (%) unless otherwise indicated.